Cargando…

Prognostic analysis of interim (18)F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy

OBJECTIVES: (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is routinely used in diffuse large B cell lymphoma (DLBCL) for staging, assessment of remission and recurrence, and estimation of therapeutic efficacy. In this study, we aimed to assess the role of an early interim PET/com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Ling, Kreissl, Michael C., Su, Liping, Wu, Zhifang, Hacker, Marcus, Liu, Jianzhong, Zhang, Xi, Bo, Yunfeng, Zhang, Hongyu, Li, Xiang, Li, Sijin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333726/ https://www.ncbi.nlm.nih.gov/pubmed/30382301 http://dx.doi.org/10.1007/s00259-018-4198-6

Ejemplares similares

Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
por: Park, Hye Lim, et al.
Publicado: (2020)

Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
por: Czibor, Sándor, et al.
Publicado: (2023)

Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET/CT in patients with follicular lymphoma
por: Zhou, Yeye, et al.
Publicado: (2019)

Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats
por: André, M., et al.
Publicado: (2011)

Prognostic values of interim and post-therapy (18)F-FDG PET/CT scanning in adult patients with Burkitt’s lymphoma
por: Wei, Wen-Xiao, et al.
Publicado: (2015)

Detection of Myocardial Metabolic Abnormalities by 18F-FDG PET/CT and Corresponding Pathological Changes in Beagles with Local Heart Irradiation
por: Yan, Rui, et al.
Publicado: (2015)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
por: Al-Ibraheem, Akram, et al.
Publicado: (2022)

Significance of initial, interim and end-of-therapy (18)F-FDG PET/CT for predicting transformation risk in follicular lymphoma
por: Xie, Mixue, et al.
Publicado: (2021)

Pediatric Hodgkin Lymphoma: Predictive value of interim (18)F-FDG PET/CT in therapy response assessment
por: Ferrari, Cristina, et al.
Publicado: (2017)

Interim (18)F-FDG PET/CT improves the prognostic value of S-IPI, R-IPI and NCCN-IPI in patients with diffuse large B-cell lymphoma
por: Jiang, Maoqing, et al.
Publicado: (2017)

Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system
por: Li, Xiang, et al.
Publicado: (2016)

Erratum to: Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system
por: Li, Xiang, et al.
Publicado: (2016)

Predictive value of baseline (18)F-FDG PET/CT and interim treatment response for the prognosis of patients with diffuse large B-cell lymphoma receiving R-CHOP chemotherapy
por: Zhu, Lili, et al.
Publicado: (2021)

Texture Analysis Improves the Value of Pretreatment (18)F-FDG PET/CT in Predicting Interim Response of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Sun, Yiwen, et al.
Publicado: (2020)

Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP
por: Kitajima, Kazuhiro, et al.
Publicado: (2019)

Utility of baseline, interim and end-of-treatment (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase
por: Chang, Yu, et al.
Publicado: (2017)

Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review
por: Adams, Hugo J. A., et al.
Publicado: (2015)

Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on (18)F-FDG PET-CT in Patients with Follicular Lymphoma
por: Liang, Jin-Hua, et al.
Publicado: (2019)

Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with (18)F-FDG PET/CT
por: Arslan, Esra, et al.
Publicado: (2022)

Baseline (18)F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
por: Jing, Fenglian, et al.
Publicado: (2023)

Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence
por: Seshachalam, Arun, et al.
Publicado: (2019)

P105: Decisional role of interim PET in relapsed/refractory classical Hodgkin Lymphoma treated with four begev cycles
por: Rusconi, Chiara, et al.
Publicado: (2022)

Prognostic value of baseline, interim and end-of-treatment (18)F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis
por: Wang, Hongxi, et al.
Publicado: (2018)

Pulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: Report of First Case and F-18 FDG PET/CT Images
por: Bilici, Ahmet, et al.
Publicado: (2011)

Prospective comparison of early interim (18)F-FDG-PET with (18)F-FLT-PET for predicting treatment response and survival in metastatic breast cancer
por: Su, Tzu-Pei, et al.
Publicado: (2021)

Intravascular large B-cell lymphoma with diffuse FDG uptake in the lung by (18)FDG-PET/CT without chest CT findings
por: Yamashita, Hiroyuki, et al.
Publicado: (2012)

PET-CT for Evaluation of Spleen and Liver (18)F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma
por: Rao, Liangjun, et al.
Publicado: (2016)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [(68)Ga]PentixaFor PET/MRI—Compared with [(18)F]FDG PET/MRI
por: Lu, Xia, et al.
Publicado: (2022)

A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [(18)F]FDG PET/CT
por: Zhang, Xiaohui, et al.
Publicado: (2021)

Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021)

CXCR4 PET imaging of mantle cell lymphoma using [(68)Ga]Pentixafor: comparison with [(18)F]FDG-PET
por: Mayerhoefer, Marius E., et al.
Publicado: (2021)

Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B‐cell lymphoma
por: Li, Xiaoqian, et al.
Publicado: (2019)

(18)FDG-PET/CT Specificity for the Detection of Lymphoma Recurrence in the Tonsils
por: West, Jonathan D., et al.
Publicado: (2021)

Interim [(18)F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
por: Sachpekidis, Christos, et al.
Publicado: (2020)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Diagnostic Value of 2-[(18)F]FDG PET/CT in a Patient with Atypical Subacute Thyroiditis: A Case Report
por: Kraus, Teresa, et al.
Publicado: (2022)

Comparison of Nasopharyngeal MR, (18) F-FDG PET/CT, and (18) F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type
por: Guo, Rui, et al.
Publicado: (2020)

Comparison of three (18)F-labeled carboxylic acids with (18)F-FDG of the differentiation tumor from inflammation in model mice
por: Wang, Hongliang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c6jhjtus30i1fa7e71vsehtgbl